Ketamine (Spravato®) Treatment
Spravato is a prescription nasal spray containing esketamine—an NMDA‑receptor antagonist approved for adults to treat treatment‑resistant depression and major depressive disorder.
Overview
✓ Covered by Insurance
✓ Rapid Symptom Relief
✓ Administered under supervision
✓ Ketamine Referrals Accepted
Treats Symptoms For
Treatment Resistant Depression
Major Depressive Disorder
Ketamine Treatment with Dr. Aydin
If you’ve tried multiple antidepressants without success, you’re not alone. Many people living with depression struggle to find relief. That’s why the FDA-approved Spravato® (esketamine) nasal spray offers a groundbreaking new option for those battling treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts.
What is Spravato®?
Spravato® (esketamine) is a form of ketamine delivered through a nasal spray, administered under medical supervision in a certified healthcare setting. Unlike traditional antidepressants that can take weeks or months to work, Spravato often produces rapid relief from depressive symptoms—even within hours to days for some patients.
Spravato works differently by targeting the NMDA receptors in the brain, helping restore healthy brain function and improve mood.
How Spravato® Works
Unlike SSRIs and SNRIs, Spravato acts on glutamate pathways in the brain.
Rapid Onset
Many patients experience symptom relief within the first few treatments.
Neuroplasticity
Spravato may help rebuild brain connections damaged by chronic depression.
Who is Spravato® for?
Spravato is FDA-approved for:
- Adults with treatment-resistant depression (TRD)
- Adults with major depressive disorder (MDD)
To qualify for Spravato, patients must have tried at least two other antidepressants without sufficient improvement.
What to expect
Initial Evaluation
Dr. Aydin will perform a comprehensive medical and psychiatric assessment to ensure Spravato is appropriate for you.
In-Office Administration
Spravato is self-administered as a nasal spray under the supervision of a trained professional.
Monitoring & Support
Patients are monitored on-site for at least 2 hours after each treatment to ensure safety and comfort.
Ongoing Treatment Plan
Treatment typically starts with 2 sessions per week for the first month, followed by a personalized maintenance schedule based on your progress.
FAQ
How is Spravato different from ketamine infusions?
Spravato contains esketamine, a form of ketamine, and is FDA-approved for specific depression indications. Ketamine infusions are often considered “off-label” and not FDA-approved for depression.
How quickly does Spravato work?
Many patients begin noticing improvements within the first few sessions, often faster than traditional antidepressants.
Does insurance cover Spravato?
Many commercial insurers, as well as Medicare and Medicaid, may cover Spravato if you meet the FDA-approved criteria. Our team will handle insurance verification and prior authorizations.
Will I feel "high" or sedated?
Some patients may feel temporary dissociation, dizziness, or sedation during treatment. These effects usually subside within a few hours.
Can I drive after Spravato?
No. You will need someone to drive you home after each session due to potential temporary side effects.
How long does each session take?
Expect to be at the office for approximately 2 hours per treatment to allow for administration and observation.
Taner Aydin, MD
Psychiatrist located in West Islip, NY. Offering in-person and telehealth mental health services for medication management, ketamine treatment, and TMS.
Patients
Patient Portal
Spruce
Practice Policies
Office Hours
Mon - Thurs: 9am-5pm
Fri: 9am - 3pm
Sat & Sun: Closed
Contact
© 2025 Taner Aydin, MD PLLC